Clinical Policy: Istradefylline (Nourianz)
Customize your policy alerts
Sign up for Arizona Complete Health Policy AZ.CP.PMN.217 alerts
Get alerted when Policy AZ.CP.PMN.217 changes without checking for updates manually.
Monitor payer policy activity
This policy governs medical-necessity and prior-authorization coverage for Nourianz (istradefylline) for Arizona Medicaid members, including AzCH-CCP and Care1st. It establishes initial and continued-therapy criteria for adults with Parkinson's disease experiencing off episodes while receiving levodopa/carbidopa.
The policy was revised to specify that the criteria also apply to Care1st.
The policy history reports that the 1Q 2021 annual review found no significant changes and updated references.
The policy history reports addition of Care1st branding and wording specifying that the criteria also apply to Care1st.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.